Back to Sections

Publication:

Surgical Technology International XX - Gynecology

Article title:

Global Endometrial Ablation

 

Order Article:

Reprint Copies:  500 - $1,960.00

1000 - $3,720.00

By e-mail: PDF Format - $69.00

 

Author(s)

Shan Biscette, MD, FACOG
Fellow of Operative Gynecologic Endoscopy
Department of Obstetrics, Gynecology and Women's Health
University of Louisville School of Medicine
Louisville, KY

Jessica Shepherd, MD
Fellow of Operative Gynecologic Endoscopy
Department of Obstetrics, Gynecology and Women's Health
University of Louisville School of Medicine
Louisville, KY

Resad P. Pasic, MD, PhD
Associate Professor of Obstetrics, Gynecology and Women's Health
Assistant Director, Section of Operative Gynecologic Endoscopy
University of Louisville School of Medicine
Louisville, KY

Abstract

Abnormal uterine bleeding (AUB) is a significant health problem for many women. Surgical treatment of AUB often follows failed attempts with first-line medical therapy. Hysterectomy, while being a definitive treatment, is a major surgical procedure with potential for significant complications and economic costs. Endometrial ablation was developed as an alternative to hysterectomy. The first-generation endometrial ablation devices required extensive training and experience to be performed effectively and safely. As a result, newer ablative devices were developed addressing the need for less technical knowledge and improved safety. Since 1997, the United States FDA has approved 5 global endometrial ablation devices for treatment of AUB attributable to benign causes. This review will focus on the technical aspects of these second-generation devices and their applications for treatment of AUB.